✦ LIBER ✦

PMH1: RIGOROUS CRITERIA FOR TREATMENT RESPONSE DIFFERENTIATED EFFICACY OF OLANZAPINE VERSUS HALOPERIDOL IN PATIENTS WITH SCHIZOPHRENIA

✍ Scribed by BJ Kinon; Z Zhao; BL Barber; JA Gilmore

Book ID: 118613858
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 71 KB
Volume: 4
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)71610-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative efficacy of olanzapine and h

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

✍ Alan Breier; Susan H Hamilton 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Comparative efficacy of olanzapine and h

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

✍ S.H. Hamilton; A. Breier; S. David 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Comparative efficacy of olanzapine and h

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

✍ A. Breier; S.H. Hamilton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 101 KB

100. Comparative efficacy of olanzapine

100. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

✍ A. Breier; S.H. Hamilton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 26 KB

PMH2: IMPROVEMENT IN QUALITY OF LIFE AND

PMH2: IMPROVEMENT IN QUALITY OF LIFE AND DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIC PATIENTS IS ASSOCIATED WITH ROBUST ACUTE TREATMENT RESPONSE OF OLANZAPINE VERSUS HALOPERIDOL

✍ BJ Kinon; Z Zhao; BL Barber; JA Gilmore 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Quetiapine versus olanzapine for the tre

Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia

✍ Pinkhas Sirota; Irit Pannet; Ady Koren; Eleonora Tchernichovsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych